Browse By Assay Result Page of OvirusTdb

The total number record retrieved from this search are 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_4461Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN4654000 to 5000 cells per wellNAMTS assay0.33 MOI20% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4462Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN4754000 to 5000 cells per wellNAMTS assay0.33 MOI20% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4463Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN2984000 to 5000 cells per wellNAMTS assay0.33 MOI50% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4464Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN14000 to 5000 cells per wellNAMTS assay0.33 MOI10% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4465Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN4654000 to 5000 cells per wellNAMTS assay1 MOI15% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4466Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN4754000 to 5000 cells per wellNAMTS assay1 MOI15% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4467Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN2984000 to 5000 cells per wellNAMTS assay1 MOI30% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4468Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN14000 to 5000 cells per wellNAMTS assay1 MOI5% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4469Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN4654000 to 5000 cells per wellNAMTS assay3 MOI10% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4470Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN4754000 to 5000 cells per wellNAMTS assay3 MOI12% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4471Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN2984000 to 5000 cells per wellNAMTS assay3 MOI25% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4472Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN14000 to 5000 cells per wellNAMTS assay3 MOI100% cell killing after 96 hoursNoNoNA No responseNANANANA26951380
OV_4509AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell100% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4510AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.001mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell75% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4511AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.0025mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell75% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4512AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.005mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell62% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4513AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell90% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4514AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.001mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell70% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4515AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.0025mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell70% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4516AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.005mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell70% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4517AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay100 VP/cell40% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4518AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.001mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay100 VP/cell35% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4519AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.0025mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay100 VP/cell30% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4520AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.005mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay100 VP/cell35% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4521AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1000 VP/cell18% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4522AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.001mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1000 VP/cell15% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4523AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.0025mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1000 VP/cell15% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4524AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.005mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1000 VP/cell15% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4525AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell100% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4526AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with Cyclophosphamide (0.0075mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell90% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4527AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with Cyclophosphamide (0.05mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell80% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4528AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell80% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4529AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with Cyclophosphamide (0.0075mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell70% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4530AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with Cyclophosphamide (0.05mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell62% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4531AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay100 VP/cell40% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4532AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with Cyclophosphamide (0.0075mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay100 VP/cell40% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4533AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with Cyclophosphamide (0.05mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay100 VP/cell40% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4534AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1000 VP/cell20% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4535AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with Cyclophosphamide (0.0075mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1000 VP/cell20% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4536AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with Cyclophosphamide (0.05mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1000 VP/cell20% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4981AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman malignant biphasic mesothelioma cell lineMTSO-211H1.0E+4 cells per wellNAMTS assay10 VP per cell78% cell viability after 72 hoursNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4982AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFNoVirus in combination with drugs pemetrexed 0.0026 mg/ml + cisplatin 0.0625Virus expressing human GM-CSF geneDSMZ GermanyHuman malignant biphasic mesothelioma cell lineMTSO-211H1.0E+4 cells per wellNAMTS assay10 VP per cell35% cell viability after 72 hoursNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4983AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFNoVirus in combination with drugs pemetrexed 0.0026 mg/ml + carboplatin 0.0625Virus expressing human GM-CSF geneDSMZ GermanyHuman malignant biphasic mesothelioma cell lineMTSO-211H1.0E+4 cells per wellNAMTS assay10 VP per cell22% cell viability after 72 hoursNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4984AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaH2261.0E+4 cells per wellNAMTS assay10 VP per cell90% cell viability after 72 hoursNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4985AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFNoVirus in combination with drugs pemetrexed 0.0026 mg/ml + cisplatin 0.0625Virus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaH2261.0E+4 cells per wellNAMTS assay10 VP per cell70% cell viability after 72 hoursNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4986AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFNoVirus in combination with drugs pemetrexed 0.0026 mg/ml + carboplatin 0.0625Virus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaH2261.0E+4 cells per wellNAMTS assay10 VP per cell72% cell viability after 72 hoursNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4987AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaJL-11.0E+4 cells per wellNAMTS assay10 VP per cell90% cell viability after 72 hoursNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4988AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFNoVirus in combination with drugs pemetrexed 0.0006 mg/ml + cisplatin 0.0019Virus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaJL-11.0E+4 cells per wellNAMTS assay10 VP per cell60% cell viability after 72 hoursNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4989AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFNoVirus in combination with drugs pemetrexed 0.0006 mg/ml + carboplatin 0.083Virus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaJL-11.0E+4 cells per wellNAMTS assay10 VP per cell70% cell viability after 72 hoursNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4990AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman malignant biphasic mesothelioma cell lineMTSO-211H1.0E+4 cells per wellNAMTS assay1 VP per cell100% cell viability after 3 daysNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4991AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman malignant biphasic mesothelioma cell lineMTSO-211H1.0E+4 cells per wellNAMTS assay10 VP per cell80% cell viability after 3 daysNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4992AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman malignant biphasic mesothelioma cell lineMTSO-211H1.0E+4 cells per wellNAMTS assay100 VP per cell60% cell viability after 3 daysNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4993AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman malignant biphasic mesothelioma cell lineMTSO-211H1.0E+4 cells per wellNAMTS assay1000 VP per cell20% cell viability after 3 daysNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4994AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaH2261.0E+4 cells per wellNAMTS assay1 VP per cell100% cell viability after 3 daysNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4995AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaH2261.0E+4 cells per wellNAMTS assay10 VP per cell90% cell viability after 3 daysNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4996AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaH2261.0E+4 cells per wellNAMTS assay100 VP per cell40% cell viability after 3 daysNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4997AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaH2261.0E+4 cells per wellNAMTS assay1000 VP per cell20% cell viability after 3 daysNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4998AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaJL-11.0E+4 cells per wellNAMTS assay1 VP per cell100% cell viability after 3 daysNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4999AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaJL-11.0E+4 cells per wellNAMTS assay10 VP per cell80% cell viability after 3 daysNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_5000AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaJL-11.0E+4 cells per wellNAMTS assay100 VP per cell40% cell viability after 3 daysNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_5001AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaJL-11.0E+4 cells per wellNAMTS assay1000 VP per cell20% cell viability after 3 daysNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_5092Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineHS294T1.0E+4 cells per wellNAMTS assay0.001 MOI70% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5093Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineHS294T1.0E+4 cells per wellNAMTS assay0.01 MOI50% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5094Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineHS294T1.0E+4 cells per wellNAMTS assay0.1 MOI20% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5095Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineHS294T1.0E+4 cells per wellNAMTS assay1 MOI10% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5096Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineHS294T1.0E+4 cells per wellNAMTS assay0.001 MOI70% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5097Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineHS294T1.0E+4 cells per wellNAMTS assay0.01 MOI60% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5098Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineHS294T1.0E+4 cells per wellNAMTS assay0.1 MOI40% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5099Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineHS294T1.0E+4 cells per wellNAMTS assay1 MOI10% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5100Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineA20581.0E+4 cells per wellNAMTS assay0.001 MOI60% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5101Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineA20581.0E+4 cells per wellNAMTS assay0.01 MOI30% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5102Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineA20581.0E+4 cells per wellNAMTS assay0.1 MOI10% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5103Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineA20581.0E+4 cells per wellNAMTS assay1 MOI100% cell killingNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5104Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineA20581.0E+4 cells per wellNAMTS assay0.001 MOI80% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5105Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineA20581.0E+4 cells per wellNAMTS assay0.01 MOI30% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5106Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineA20581.0E+4 cells per wellNAMTS assay0.1 MOI10% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5107Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineA20581.0E+4 cells per wellNAMTS assay1 MOI100% cell killingNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5108Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman lung cancer cell lineA5491.0E+4 cells per wellNAMTS assay0.001 MOI100% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5109Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman lung cancer cell lineA5491.0E+4 cells per wellNAMTS assay0.01 MOI80% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5110Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman lung cancer cell lineA5491.0E+4 cells per wellNAMTS assay0.1 MOI50% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5111Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman lung cancer cell lineA5491.0E+4 cells per wellNAMTS assay1 MOI10% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5112Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman lung cancer cell lineA5491.0E+4 cells per wellNAMTS assay0.001 MOI100% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5113Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman lung cancer cell lineA5491.0E+4 cells per wellNAMTS assay0.01 MOI100% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5114Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman lung cancer cell lineA5491.0E+4 cells per wellNAMTS assay0.1 MOI60% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5115Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman lung cancer cell lineA5491.0E+4 cells per wellNAMTS assay1 MOI10% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5116Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineSK-MEL-21.0E+4 cells per wellNAMTS assay0.001 MOI60% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5117Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineSK-MEL-21.0E+4 cells per wellNAMTS assay0.01 MOI40% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5118Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineSK-MEL-21.0E+4 cells per wellNAMTS assay0.1 MOI10% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5119Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineSK-MEL-21.0E+4 cells per wellNAMTS assay1 MOI100% cell killingNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5120Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineSK-MEL-21.0E+4 cells per wellNAMTS assay0.001 MOI90% cell killingNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5121Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineSK-MEL-21.0E+4 cells per wellNAMTS assay0.01 MOI70% cell killingNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5122Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineSK-MEL-21.0E+4 cells per wellNAMTS assay0.1 MOI20% cell killingNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5123Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineSK-MEL-21.0E+4 cells per wellNAMTS assay1 MOI100% cell killingNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5126Semliki forest viruswild type SFV4RNAAlphaviridaeNoneYesNoNoNAMurine neuroblastoma cell lineNXS220000 cells per wellNAMTS assay0.001 MOI100% cell viability after 72 hoursNoNoNA No responseNANAInduce production of IFN gammaNA27637889
OV_5127Semliki forest viruswild type SFV4RNAAlphaviridaeNoneYesNoNoNAMurine neuroblastoma cell lineNXS220000 cells per wellNAMTS assay0.01 MOI80% cell viability after 72 hoursNoNoNA No responseNANAInduce production of IFN gammaNA27637889
OV_5128Semliki forest viruswild type SFV4RNAAlphaviridaeNoneYesNoNoNAMurine neuroblastoma cell lineNXS220000 cells per wellNAMTS assay0.1 MOI70% cell viability after 72 hoursNoNoNA No responseNANAInduce production of IFN gammaNA27637889
OV_5129Semliki forest viruswild type SFV4RNAAlphaviridaeNoneYesNoNoNAMurine neuroblastoma cell lineNXS220000 cells per wellNAMTS assay1 MOI42% cell viability after 72 hoursNoNoNA No responseNANAInduce production of IFN gammaNA27637889
OV_5130Semliki forest viruswild type SFV4RNAAlphaviridaeNoneYesNoNoNAMurine neuroblastoma cell lineNXS220000 cells per wellNAMTS assay10 MOI30% cell viability after 72 hoursNoNoNA No responseNANAInduce production of IFN gammaNA27637889
OV_5131Semliki forest virusSFVmiRTRNAAlphaviridaeInsertional mutagenesis at 3UTr for miR124, 125 and 134YesNoNoNAMurine neuroblastoma cell lineNXS220000 cells per wellNAMTS assay0.001 MOI100% cell viability after 72 hoursNoNoNA No responseNANAInduce production of IFN gammaNA27637889
OV_5132Semliki forest virusSFVmiRTRNAAlphaviridaeInsertional mutagenesis at 3UTr for miR124, 125 and 134YesNoNoNAMurine neuroblastoma cell lineNXS220000 cells per wellNAMTS assay0.01 MOI82% cell viability after 72 hoursNoNoNA No responseNANAInduce production of IFN gammaNA27637889